Empower Clinics Closes Up 77% On 25M Shares. This Is Why ... And This Is Where It Is Going

With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would  kill for.  Patient visits increased 800% in February. 590% in March and  480% for Q1.

More importantly, it is the only small cap company on the continent  (that we know of) that is capable of launching COVID-19 Antibody  Testing for individuals and businesses nationwide.  Why?  Because its  simply not enough to be able to get your hands on some test kits.  The  real challenge is having the infrastructure in place to test people in  clinics, via drive though and in the workplace.

It's pretty much a military precision process that few small cap CEO's could handle.

But Empower Clinics CEO, Steven McAuley, is Six Sigma certified  under the quality initiative of legendary GE (General Electric) Chairman  Jack Welch. We've never seen a Six Sigma certified CEO in the Canadian  small cap markets. Never .... which explains how McAuley has been able  to guide Empower Clinics through the most disruptive retail environment  in recent history and turn it into significant growth.

And now he's set his sights on Antibody Testing.  He's not just looking, he's already started.

Forget NetFlix Tonight.  Watch this.